Impact of pre-existing interstitial lung abnormalities on pneumonitis risk and survival in chemo-naive patients with non-small-cell lung cancer receiving pembrolizumab plus chemotherapy. - Machiyama H; Matsumoto K; Shiroyama T; Miyazaki A; Komuta K; Tamiya M; Tsukaguchi A; Tamiya A; Kinehara Y; Moritomo K; Shoshihara N; Kuge T; et al. (Respiratory medicine, 2026)